Zinzino's Remarkable Revenue Growth in August 2025: A 46% Surge

Zinzino AB's Preliminary Sales Report for August 2025



Zinzino AB (PUBL.), the innovative health and wellness company, has released its preliminary sales report for August 2025, showcasing impressive growth metrics that highlight its ongoing success in the competitive market. In August alone, Zinzino achieved a remarkable revenue increase of 46%, reaching SEK 243.6 million compared to SEK 167.0 million in the previous year.

Key Highlights:


  • - Overall Revenue Growth: The company reported a total group revenue of SEK 246.9 million, indicating a 38% growth from SEK 179.2 million compared to the previous year's figures.
  • - Accumulative Revenue Performance: From January to August 2025, Zinzino's accumulated revenue increased by 55%, amounting to SEK 2,028.7 million, compared to SEK 1,309.9 million in 2024.

Breakdown of Revenue by Regions:


Zinzino's substantial revenue growth during August can be attributed to impressive performances across various regions:
  • - The Nordics: SEK 26.3 million, a 10% increase compared to SEK 24.0 million last year.
  • - Central Europe: Revenue soared to SEK 72.2 million, marking a 58% increase from SEK 45.7 million.
  • - Eastern Europe: Experienced a minor dip, reaching SEK 28.8 million, which reflects a 7% decrease.
  • - Southwest Europe: Saw a strong performance of SEK 40.9 million, up by 24% from SEK 32.9 million.
  • - The Baltics: Grew to SEK 9.6 million, an increase of 43%.
  • - North America: Witnessed explosive growth, achieving SEK 41.1 million, a staggering 163% increase from last year’s SEK 15.6 million.
  • - Asia-Pacific: A remarkable 131% growth, bringing revenue to SEK 22.6 million, compared to SEK 9.8 million.
  • - Africa: Recorded SEK 2.1 million, up 62% from SEK 1.3 million.

Faun Pharma Performance:


Although Zinzino's sales soared, Faun Pharma saw a 73% decline in external sales, with revenue dropping to SEK 3.3 million from SEK 12.2 million. This discrepancy highlights the challenges faced by Faun Pharma amidst Zinzino's success.

Conclusion:


Zinzino’s impressive financial results for August reflect its growing market presence and strong sales in various sectors, particularly in North America and the Asia-Pacific region. The significant increase in revenue confirms the efficacy of Zinzino's sales strategies and product offerings that resonate well with consumers. As they navigate fluctuating market dynamics, Zinzino continues to establish itself as a leader in the health and wellness industry, showcasing resilience and adaptability in the face of challenges.

For further insights on Zinzino's strategies and detailed analysis of its performance, the company's executives Dag Bergheim Pettersen and Fredrik Nielsen are available for comments and inquiries. This promising report sets a positive tone for Zinzino's future endeavors as it aims to build on its recent successes in the coming months.

Topics Financial Services & Investing)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.